Lauren Philp
Overview
Explore the profile of Lauren Philp including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
78
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saini A, Orav J, Sisodia R, Philp L
J Gynecol Oncol
. 2025 Mar;
PMID: 40051285
Objective: To determine if preoperative Patient-Reported Outcome Measures (PROMs) can be used to predict post-operative health care utilization in gynecology oncology patients. Methods: A retrospective study was performed after Institutional...
2.
Mazina V, Devins K, Philp L, Bercow A, James K, Bregar A, et al.
Int J Gynecol Cancer
. 2023 Aug;
33(9):1434-1439.
PMID: 37567599
Objective: The primary objective was to characterize the rate of lymph node involvement in a cohort of patients with primary ovarian endometrioid adenocarcinoma. Additionally, we sought to quantify the recurrence...
3.
Bouberhan S, Bar-Peled L, Matoba Y, Mazina V, Philp L, Rueda B
Cancer Drug Resist
. 2023 Jul;
6(2):345-357.
PMID: 37457127
Epithelial ovarian cancer (EOC) is treated in the first-line setting with combined platinum and taxane chemotherapy, often followed by a maintenance poly (ADP-ribose) polymerase inhibitor (PARPi). Responses to first-line treatment...
4.
Philp L, Alimena S, Sullivan M, Del Carmen M, Bregar A, Eisenhauer E, et al.
Int J Gynecol Cancer
. 2023 Jan;
33(5):770-777.
PMID: 36639193
Objective: Race remains a significant predictor of poor outcomes in women with gynecologic cancer and minority patients consistently report worse quality of life during cancer treatment. Disparities between patients in...
5.
Alimena S, Philp L, Orav E, Sullivan M, Del Carmen M, Goodman A, et al.
Int J Gynecol Cancer
. 2022 Feb;
32(6):781-787.
PMID: 35169070
Objective: Chemotherapy has multiple adverse effects, including chemotherapy-related cognitive impairment, the phenomenon colloquially referred to as 'chemobrain'. The objective of this study was to understand patient-reported experiences of this phenomenon...
6.
Russo A, Lee L, Wo J, Niemierko A, Park D, Alban G, et al.
Am J Clin Oncol
. 2021 Nov;
45(1):36-39.
PMID: 34817442
Objectives: The objective of this study was to determine if deficiency of mismatch repair (dMMR) proteins in patients with early-stage favorable endometrial cancer treated with vaginal brachytherapy (VB) is associated...
7.
Sisodia R, Alimena S, Ferris W, Saini A, Philp L, Sullivan M, et al.
Gynecol Oncol
. 2021 Nov;
164(1):113-119.
PMID: 34763938
Introduction: Patient reported outcome measures (PROMs) are associated with improved overall survival in patients with metastatic malignancy; however, routine collection of PROMs is nascent. Little is known about PROs in...
8.
Sullivan M, Philp L, Kanbergs A, Safdar N, Oliva E, Bregar A, et al.
Gynecol Oncol
. 2021 Jul;
162(3):613-618.
PMID: 34247769
Objective: The objective of this study was to determine the proportion of patients with a pre-invasive endometrial lesion who meet Mayo criteria for lymph node dissection on final pathology to...
9.
Chan H, Haerle S, Daly M, Zheng J, Philp L, Ferrari M, et al.
PLoS One
. 2021 Apr;
16(4):e0250558.
PMID: 33930063
An integrated augmented reality (AR) surgical navigation system that potentially improves intra-operative visualization of concealed anatomical structures. Integration of real-time tracking technology with a laser pico-projector allows the surgical surface...
10.
Alimena S, Sullivan M, Philp L, Dorney K, Hubbell H, Carmen M, et al.
Gynecol Oncol
. 2020 Nov;
160(1):252-259.
PMID: 33139040
Objective: Our goal was to pragmatically describe patient reported outcomes (PROs) in a typical clinic population of vulvar cancer patients, as prior studies of vulvar cancer PROs have examined clinical...